If NVDA trust this company with 50 mil (small), RXRX could see 20 soon ( max).
It seems like many investors were not aware of RXRX and what they are doing in the lab to autonomously collect data and what they are doing with AI on that data for speeding up drug discovery. I guess that changed today with the NVDA announcement!
this is huge. After hours, this can pop over 20.NVDA backing.. buckle up for after hours.. this is going to double... $Recursion Pharmaceuticals, Inc.(RXRX)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
